Altium, IPC Education Foundation, and Arduino Announce Student Electronics Design Competition
Altium LLC, the leading printed circuit board (PCB) software company, is partnering with the IPC Education Foundation (IPCEF) and Arduino to launch the first student electronics design challenge to engage, educate, and enhance printed circuit board (PCB) design capabilities while developing STEM solutions to environmental challenges.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210908005457/en/
Upverter Education, a division of Altium, the IPC Education Foundation, and Arduino are partnering to create the first student design competition to engage, educate, and enhance students’ proficiencies in PCB design, with a focus on solving some of the world’s most pressing environmental challenges. (Photo: Altium LLC)
The Innovation for Environmental Change 2021 International Student Design Competition (#PCBeTheChange) engages student teams to help address common environmental concerns using Altium’s educational tools with Arduino hardware.
Teams from high schools and colleges will be using Altium’s Upverter Modular PCB design software and the Arduino Portenta H7 to create a prototype design that will improve the environment in each team’s respective local area. The teams will be challenged to tackle one or more environmental concerns, such as air pollution, water quality and solar energy capture.
As Lotte Nørregaard Andersen, Head of Arduino Education, elaborates, "At Arduino, we believe that it is very crucial to empower scientists of the future to address common challenges of our time using technology. We’re delighted to partner with Altium LLC and the IPC Education Foundation in the Innovation for Environmental Change 2021 International Student Design Competition; this competition really aligns with our goal of creating the next generation of STEM solutions."
Participating teams can enter the design challenge while harnessing Altium’s Upverter Education training modules plus the Upverter Modular tool. Altium features multiple educational initiatives designed to support high school STEM teachers and students, along with programs to support college students and industry professionals.
“Students learning electronics design can get a comprehensive overview of how to design their own hardware with guided training in easy-to-understand modules. We’re honored to support the next generation of electronics designers by providing the curriculum and tools students need for the contest,” adds Rea Callender, Vice President of Upverter Education.
Winning teams will be eligible to win cash prizes for each category: high school and college: $1500 (1st prize), $750 (2nd prize) and $500 (3rd prize), free access to IPC APEX EXPO in San Diego, CA from January 25-27, 2022 as well as virtual access to AltiumLive 2022 CONNECT, co-located alongside the IPC APEX EXPO at the San Diego Convention Center. Designs will be featured on display at the IPC Design Booth; awards will be presented at the IPC APEX EXPO STEM Outreach Event.
Charlene Gunter, Senior Director of IPCEF shares, “We believe that opportunities and experiences like this will allow students to gain awareness and access to the electronics manufacturing industry and in turn help them reach their career goals. This collaborative partnership with Altium, Upverter Education, and Arduino showcases our mutual goals of engaging and educating students in PCB design, and we look forward to seeing the creativity and solutions the teams will create.”
Open registration is available via Upverter Education for the design challenge beginning on Monday, August 16th and runs through Friday, October 1st; team designs must be received online by Friday, November 19th. Competition winners will be announced on Friday, December 17th, followed by virtual presentations for the first place, and runner-up entrants.
For more information, please contact Upverter.Education@altium.com.
About Altium
Altium, LLC (ASX:ALU) is a global software company headquartered in San Diego, California, accelerating the pace of innovation through electronics. For over 30 years, Altium has been delivering software that maximizes the productivity of PCB designers and electrical engineers. From individual inventors to multinational corporations, more PCB designers and engineers choose Altium software to design and realize electronics-based products.
About Upverter Education
Upverter Education, launched by Altium in September 2020, is addressing an important societal need by empowering STEM educators teaching engineering, electronics design, and robotics with free essential tools and classroom resources. The program has been honored with multiple awards, including the EdTech Breakthrough Award, for Best Engineering Learning Solution and the Gold STEVIE® American Business Award, further validating Altium’s innovative approach to supporting STEM education.
About IPC Education Foundation (IPCEF)
The IPC Education Foundation creates awareness of the careers the electronics manufacturing industry has to offer students in high school and college by providing them with opportunities to access people, courses, and knowledge through key programs: 1) The IPC Student Chapter program provides scholarships, industry-standard education, industry connections, and access to hands-on competitions, especially with the support of industry experts and professionals; 2) IPC Video Subscription Libraries provide access to industry-relevant content to students in high school and college, and 3) a variety of engagement initiatives like in-person/virtual events, webinars, and classroom activities.
About Arduino
Arduino is the leading open-source hardware and software company in the world. Born to provide an easy-to-use platform for anyone making interactive projects, Arduino has reached a growing community and adapted to new needs and challenges, branching out into products for IoT, wearables, 3D printing, and embedded environments. As of today, the Arduino community included approximately 30 million active users.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210908005457/en/
Contact information
Xenia Moore
Altium
Senior Manager of PR and Brand Communications
pr@altium.com
Sandy Gentry
IPC
Director, Brand Communications
sandygentry@ipc.org
Luisa Castiglioni
Arduino
PR Manager
press@arduino.cc
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD7.1.2026 13:30:00 EET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for COMP360, enabling the initiation of a late-stage clinical trial in patients with PTSD. Compass management, along with KOL and industry leaders, will host a webinar today to discuss the company’s clinical trial plans for PTSD, as well as commercial preparations for treatment-resistant depression (TRD) from 10:00-11:30 am ET on January 7th. “PTSD is one of the most challenging mental health conditions, with approximately 13 million adults in the U.S. living with persistent symptoms and limited treatment options,” said Dr. Guy Goodwin, Chief Medical Officer at Compass Pathways. “We are pleased to advance our clinical development - the unmet need is profound, and it demands bold innovation. We believe COMP360 has the potential to tra
Stallergenes Greer Expands Venom Immunotherapy Production Capacity With Acquisition of Entomon s.r.l.7.1.2026 12:07:00 EET | Press release
Stallergenes Greer, a global leader in allergy therapeutics, today announced that it has entered into an agreement to acquire Entomon s.r.l., an Italian company specialising in the production of certified stinging-insect venom extracts, notably of the Hymenoptera order, used for the manufacture of diagnostic preparations and Venom Immunotherapy (VIT). The transaction is expected to close by the end of January. Entomon, currently recognised as the only company in Europe capable of extracting pure venom from Hymenoptera insects, produces pharmaceutical-grade insect venom using proprietary techniques (Entomon Capillary Extracted Venom®) for medical use. Through this acquisition, Stallergenes Greer bolsters its venom manufacturing capabilities and supply of raw materials for life-saving VIT treatments, whilst safeguarding patient care continuity. Hymenoptera venom allergy is the most common trigger of severe anaphylaxis in adults1. According to the EAACI guidelines on venom immunotherapy,
ARIS Announces New CEO to Lead Agentic AI-led Strategy7.1.2026 11:00:00 EET | Press release
CEO Appointment ARIS, a global leader in process intelligence and transformation software, today announced the appointment of Guillaume Bacuvier as Chief Executive Officer. Guillaume will lead ARIS through its next phase of growth as a fully standalone company, accelerating its evolution from a market leader in Process Intelligence into a foundational platform for enterprises deploying and governing Agentic AI. Guillaume brings deep international leadership experience across technology, data, and software-enabled businesses, with a proven track record of scaling global platforms and leading complex organisations. After starting as a strategic consultant at Booz Allen Hamilton, Guillaume spent over a decade at Google, rising to Vice President in EMEA where he built and scaled some of Google’s largest data-driven businesses in Europe and held P&L responsibility across multiple countries. In the last decade, Guillaume has served as CEO of multi-continent, data-centric companies including
I Squared Capital Acquires Ramudden Global, a Leader in Traffic Management and Infrastructure Safety7.1.2026 10:00:00 EET | Press release
I Squared Capital, a leading global infrastructure investment manager, today announced that, through its flagship fund, it has agreed to acquire Ramudden Global, from funds advised by Triton Partners (“Triton”), a leading European mid-market sector-specialist investor. Ramudden Global is a leading international provider of traffic management and infrastructure safety services supporting the maintenance and upgrade of essential transport and utility networks. The company operates more than 190 depots across 13 countries in Europe and North America delivering mission-critical services that help to ensure safety, regulatory compliance and continuity of service across road, utility and broader infrastructure works. This investment underscores I Squared Capital’s commitment to investing in essential, regulated, infrastructure businesses that underpin public safety, mobility and economic activity. Ramudden operates in markets where demand is steady and growing and benefits from deep commerci
RoslinCT and BOOST Pharma Announce Strategic Manufacturing Agreement to Advance Cell Therapy for Infants with Osteogenesis Imperfecta7.1.2026 10:00:00 EET | Press release
RoslinCT, a global contract development and manufacturing organization (CDMO) specializing in advanced cell therapies, and BOOST Pharma, a clinical-stage biotechnology company developing first-in-class cell therapies for rare paediatric skeletal diseases, today announced a strategic manufacturing partnership to support the development of BOOST Pharma’s cell therapy, BT-101, for the treatment of infants with Osteogenesis Imperfecta (OI), also known as brittle bone disease. Under the service agreement, BOOST Pharma has transferred its manufacturing process to RoslinCT’s state-of-the-art facilities in Edinburgh, Scotland. The partnership will progress toward GMP manufacturing of starting materials and clinical drug product, supporting Phase III clinical development of BT-101. The therapy is an allogeneic mesenchymal stem cell (MSC) product designed to address the underlying cause of OI at the earliest stages of life. BOOST Pharma was founded on pioneering science originating from Karolins
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom